Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2003;101:1333-1344
© 2003 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Branch, D. W.
Right arrow Articles by Khamashta, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Branch, D. W.
Right arrow Articles by Khamashta, M. A.

HIGH-RISK PREGNANCY SERIES: AN EXPERT'S VIEW

Antiphospholipid Syndrome: Obstetric Diagnosis, Management, and Controversies

D. Ware Branch, MD and Munther A. Khamashta, MD, PhD

From the Department of Obstetrics and Gynecology, The University of Utah Health Sciences Center, Salt Lake City, Utah; and Lupus Research Unit, Rayne Institute, King’s College, St Thomas’ Hospital, London, United Kingdom.

Address reprint requests to: D. Ware Branch, MD, Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, 30 North 1900 East, Suite 2B200 MC, Salt Lake City, Utah 84132; E-mail: ware.branch{at}hsc.utah.edu.

Antiphospholipid syndrome, a condition characterized by one or more thrombotic or pregnancy-related clinical features in association with medium to high levels of antiphospholipid antibodies, has emerged as an important diagnostic consideration in several medical fields. Antiphospholipid syndrome is one of the few treatable causes of pregnancy loss, and successful pregnancy rates of 70% or more can be achieved with appropriate treatment. Heparin, usually combined with low-dose aspirin, is used in patients at risk for thrombosis. Pregnancy in these women is associated with increased rates of preeclampsia, placental insufficiency, and preterm delivery, so that attentive clinical care is required for best outcomes. Recent studies indicate that women at low risk for thrombosis may be treated with low-dose aspirin. However, remaining controversies and unanswered questions in the field of antiphospholipid syndrome are a source of clinical confusion. This review highlights the most important controversies, taking into account the results of recent obstetric treatment trials and our own clinical experience.




This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
S. M. Nelson and I. A. Greer
The potential role of heparin in assisted conception
Hum. Reprod. Update, August 12, 2008; (2008) dmn031v1.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
G Ruiz-Irastorza and M. Khamashta
Lupus and pregnancy: ten questions and some answers
Lupus, May 1, 2008; 17(5): 416 - 420.
[PDF]

Home page
 Rheumatology (Oxford)Home page
M. Gayed and C. Gordon
Pregnancy and rheumatic diseases
Rheumatology, November 1, 2007; 46(11): 1634 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. Cleary-Goldman, B. Bettes, J. N. Robinson, E. Norwitz, and J. Schulkin
Thrombophilia and the Obstetric Patient
Obstet. Gynecol., September 1, 2007; 110(3): 669 - 674.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J. A Gomez-Puerta, R. Cervera, G. Espinosa, R. A Asherson, M. Garcia-Carrasco, I. P da Costa, D. C O Andrade, E. F Borba, A. Makatsaria, S. Bucciarelli, et al.
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases
Ann Rheum Dis, June 1, 2007; 66(6): 740 - 746.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A Tincani, D Bompane, E Danieli, and A Doria
Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome)
Lupus, March 1, 2006; 15(3): 156 - 160.
[Abstract] [PDF]

Home page
 LupusHome page
M L Bertolaccini and M A Khamashta
Laboratory diagnosis and management challenges in the antiphospholipid syndrome
Lupus, March 1, 2006; 15(3): 172 - 178.
[Abstract] [PDF]

Home page
 Ann Rheum DisHome page
M L Bertolaccini, S Gomez, J F P Pareja, A Theodoridou, G Sanna, G R V Hughes, and M A Khamashta
Antiphospholipid antibody tests: spreading the net
Ann Rheum Dis, November 1, 2005; 64(11): 1639 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. N. Quinones, D. N. James, D. M. Stamilio, K. L. Cleary, and G. A. Macones
Thromboprophylaxis After Cesarean Delivery: A Decision Analysis
Obstet. Gynecol., October 1, 2005; 106(4): 733 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. H. James, C. D. Bushnell, M. G. Jamison, and E. R. Myers
Incidence and Risk Factors for Stroke in Pregnancy and the Puerperium
Obstet. Gynecol., September 1, 2005; 106(3): 509 - 516.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A Ruffatti, M Favaro, M Tonello, G De Silvestro, V Pengo, G Fais, V Suma, S Chiarelli, and S Todesco
Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study
Lupus, February 1, 2005; 14(2): 120 - 128.
[Abstract] [PDF]

Home page
 Obstet GynecolHome page
D. P. Damron and W. Branch
Antiphospholipid Syndrome: Obstetric Diagnosis, Management, and Controversies
Obstet. Gynecol., October 1, 2003; 102(4): 873 - 873.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Obstetricians and Gynecologists.